NAC alleviates xCT system dysfunction caused by RGS4 deficiency by preserving cysteine and glutamate exchange, offering a targeted method to restore glutamatergic signaling in the prefrontal cortex for this schizophrenia subtype. Here, SLC7A11 is linked to schizophrenia.